The World Market for Personalized Medicine Tests for Cancer

The World Market for Personalized Medicine Tests for Cancer

This report, Personalized Medicine Tests for Cancer, provides an authoritative look at the market for companion and personalized medicine testing for cancer. The report includes a market size and forecast for personalized medicine testing by geography (US, EU, ROW). Company profiles are included and products are identified by status (on the market, in development)


  • Executive Summary
    • The Scourge of Cancer
    • Definitions of Companion Diagnostics and Cancer Diagnostics
    • Types of Tests Included
    • Marketing Personalized Medicine-Based Cancer Tests
    • Market
    • Point of View
  • Introduction
    • Cancer Treatments
      • Table Biomarkers Used in Cancer Tests
    • Cancer Risk Assessment
    • Cancer Screening
    • Cancer Monitoring
    • Prognosis Assessment
    • Technologies Used
      • Immunoassays:
      • Immunohistochemistry (IHC):
      • Flow Cytometry:
      • In Situ Hybridization:
      • Nucleic Acid Amplification Technologies:
      • Analysis of Gene Expression Patterns (Gene Signatures):
      • Microarrays:
      • Sequencing Technologies:
      • Mass Spectrometry:
      • Liquid Biopsies:
      • Information Technology:
    • Test Targets
      • HER2 Overexspression
      • EGFR
      • KRAS Mutations
      • BRAF Mutations
      • UGT1A1 Genetic Variants
      • 5-Flurouracil Therapy
      • PIK3CA Mutations
      • KIF6 Mutations
      • ALK Mutations
  • Market Analysis
    • Products on the Market
      • Table Personalized Medicine Testing Products for Cancer on the Market and In Development
      • Market Analysis
        • Table The Market for Personalized Medicine Testing for Cancer by Geographic Region , 2016 and 2021 $ Millions
      • Drivers
      • Diagnostic Companies and Pharmaceutical Companies
      • Growth by Geography
  • Company Profiles.
    • 20/20 GeneSystems, Inc.
      • Company Overview
      • Products
    • Abbott Laboratories
      • Company Overview
      • Products
    • ACT Genomics Co., Ltd.
      • Products
    • Adaptive Biotechnologies Corporation
      • Company Overview
      • Products
    • Admera Health (A GENEWIZ Company)
      • Company Overview
    • Agena Bioscience Inc.
      • Company Overview
      • Products
    • Agendia NV
      • Company Overview
    • Amoy Diagnostics Co., Ltd.
      • Company Overview
      • Products
    • ARKRAY, Inc.
      • Company Overview
      • Products
    • Biocartis
      • Company Overview
      • Products
      • Pharmaceutical Company Agreements
    • bioMérieux SA
      • Company Overview
      • Products
    • Cepheid (Danaher)
      • Company Overview
      • Products
    • Genomic Health, Inc.
      • Company Overview
      • Products
    • Genoptix (A Novartis Company)
      • Company Overview
    • Luminex Corporation
      • Company Overview
      • Products
    • Myriad Genetics, Inc.
      • Company Overview
      • Products
    • Qiagen N.V.
      • Company Overview
      • Products
    • QuanDx Inc.
      • Company Overview
    • Quest Diagnostics
      • Company Overview
      • Products
    • Qvella Corporation
    • RiboMed Biotechnologies, Inc.
      • Company Overview
      • Products
    • Roche
      • Company Overview
      • Products
    • Siemens Healthcare
      • Company Overview
      • Products
    • Symbiodx
      • Company Overview
      • Products
    • Theranostics Health Inc. (Acquired by Avant Diagnostics, Inc.)
      • Overview
      • Products
    • Thermo Fisher Scientific, Inc.
      • Company Overview
      • Products

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings